Natus Medical (BABY) Tops Q4 EPS by 1c; Updates FY15 Outlook

Natus Medical (NASDAQ: BABY) reported Q4 EPS of $0.40, $0.01 better than the analyst estimate of $0.39. Revenue for the quarter came in at $94 million versus the consensus estimate of $93.28 million.

Natus Medical sees Q1 2015 EPS of $0.20-$0.30, versus the consensus of $0.29. Natus Medical sees Q1 2015 revenue of $88-90 million, versus prior guidance of $87-89 million and the consensus of $88.3 million.

Natus Medical sees FY2015 EPS of $1.42-$1.46, versus prior guidance of $1.40-$1.44 and the consensus of $1.44. Natus Medical sees FY2015 revenue of $373-375 million, versus prior guidance of $367-369 million and the consensus of $367.1 million.

For earnings history and earnings-related data on Natus Medical (BABY) click here.

You May Also Be Interested In

• Equifax (EFX) shares tumble on weak Q1 revenue, guidance miss
• Crown Castle (CCI) Tops Q1 EPS by 1c; maintains outlook for FY24
• Las Vegas Sands (LVS) Tops Q1 EPS by 14c